Epinephrine Injection Auto-Injectors 0.3mg

Epinephrine Injection Auto-Injectors 0.3mg

Epinephrine Auto-Injectors (0.3 mg) are designed for treating life-threatening allergic emergencies in individuals at risk for severe allergic reactions. Each injector delivers 0.3mg of epinephrine in 0.3mL. 
  • Specifically formulated for the emergency treatment of severe allergic reactions, delivering 0.3mg of epinephrine per dose
  • Includes 2 yellow epinephrine auto-injectors for use and 1 grey trainer for safe practice
  • Ideal for individuals with a history of serious allergic emergencies


Brand: Mylan
SIGN IN or REGISTER FOR AN ACCOUNT to see pricing

PO-6740  

  This is a special order item. Please allow 2-3 week for delivery. Special Order Item are non-returnable unless defective.

  This item is ineligible for USPS shipping due to unpredictable ship durations and the sensitivity of this product to weather conditions.

This product is DSCSA tracked.

  Before an order for diagnostic or pharmaceutical products can be processed AMCON is required to keep on file a copy of the Practitioner's therapeutic license. Practitioners are solely responsible for complying by the laws of their state.  AMCON assumes no liability for practitioner compliance.
We cannot accept returns on pharmaceutical products.

Can only ship within US. This product can only be shipped within the United States.

Related Products

Already an Amcon Customer?

Let's get you taken care of.

Do you have access to order on our Web Store/JAOS?

  • If you have access to the Amcon Web Store, visit our web store, click the link in the top right to sign in, and purchase these products today.
  • If you have access, sign in to JAOS here. If these products are not on your order form, contact your sales representative.

Don't have web access but have a customer number with Amcon Labs?

  • Contact our sales team today, and we will take care of you as soon as possible!

Interested in learning more?

Stay up to date with the latest from Amcon Labs by joining our free newsletter:

. .